All News #Library
Norwich Pharmaceuticals Generic Rifaximin Receives Tentative Approval in US
20 Jun 2024 //
FDA
Norwich`s Generic Rifaximin Receives Approval in the U.S.
02 Jun 2023 //
FDA
Norwich`s Generic Lisdexamfetamine Dimesylate Receives Approval in the U.S.
19 Jan 2023 //
FDA

Market Place
Sourcing Support